News

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

The best way to

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

How can you tell a good

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

How can you tell a good

Wall Street underperformed over the past one month, with the S&P 500 losing 0.9% (as of Feb. 27, 2026), the Dow Jones retreating 1.3% and the Nasdaq Composite nosediving 3.4%. However, the small-cap

Costco Wholesale Corporation’s COST technology investments are translating into measurable productivity gains. While the company remains committed to its warehouse expansion, it is increasingly

Venture Global (VG) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.33 per share a year ago. These

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today March 2nd:

Air France-KLM AFLYY: This airline company, which is the world leader in terms of

U.S. stocks suffered a blow, and the bull run halted in February, with Wall Street concluding a Volatile month. Market participants remained concerned about the continuity of the AI (artificial

Dollar General Corporation DG is signaling a significant shift toward operational efficiency by making a dedicated push into artificial intelligence. The appointment of a new head of AI marks a

U.S. stock markets started 2026 on a positive note. Volatility reappeared on Wall Street in February, buy, predominantly due to market participants’ concerns about the continuity of artificial

Shares of Moderna MRNA rose about 4% on Friday after the company announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization to

EchoStar (SATS) came out with a quarterly loss of $1.03 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to earnings of $1.24 per share a year ago. These figures are

Integra LifeSciences Holdings Corporation IART delivered adjusted earnings per share (EPS) of 83 cents for the fourth quarter of 2025, which beat the Zacks Consensus Estimate by 4.7%. The metric

Penumbra, Inc. PEN reported fourth-quarter 2025  adjusted earnings per share (EPS) of $1.18 compared with 85 cents in the year-ago quarter. The figure surpassed the Zacks Consensus Estimate by

Norwegian Cruise Line (NCLH) came out with quarterly earnings of $0.28 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.26 per share a year ago. These figures

Walmart Inc. WMT Sam’s Club U.S. delivered steady performance in the fourth quarter of fiscal 2026, supported by strong transaction growth and continued digital adoption. While the headline sales

Here are three stocks with buy rank and strong value characteristics for investors to consider today, March 2nd:  

Encore Capital Group ECPG: This international specialty finance company, which

Equinix, Inc. EQIX and Canada Pension Plan Investment Board (CPP Investments) announced that they have jointly agreed to acquire atNorth from Partners Group for $4.2 billion, with the valuation

Delek US Holdings, Inc. DK reported fourth-quarter 2025 adjusted earnings per share of 44 cents in contrast to the Zacks Consensus Estimate of a 25-cent loss. The bottom line also marked a sharp

Oil futures jumped sharply following an escalating Middle East conflict that is now threatening global energy infrastructure. Futures tied to Brent crude, the international benchmark, surged to

RadNet (RDNT) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago. These figures are

Zymeworks Inc. (ZYME) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.31 per share a year ago. These figures

After navigating an unusually volatile cost environment, Mondelez International, Inc. MDLZ is balancing pricing discipline with the need to protect volumes. The question is whether organic sales